ASLAN Pharmaceuticals Announces $20m Private Placement Led by BVF Partners L.P. With The Potential to Receive up to an Additional $80m
Previous
Previous
Inozyme Pharma Reports Full Year 2022 Financial Results and Provides Business Highlights
Next
Next